These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 22200807

  • 1. PAI-1 mRNA expression and plasma level in rheumatoid arthritis: relationship with 4G/5G PAI-1 polymorphism.
    Muñoz-Valle JF, Ruiz-Quezada SL, Oregón-Romero E, Navarro-Hernández RE, Castañeda-Saucedo E, De la Cruz-Mosso U, Illades-Aguiar B, Leyva-Vázquez MA, Castro-Alarcón N, Parra-Rojas I.
    Rheumatol Int; 2012 Dec; 32(12):3951-6. PubMed ID: 22200807
    [Abstract] [Full Text] [Related]

  • 2. Association of PAI-1 4G/5G and -844G/A gene polymorphisms and changes in PAI-1/tissue plasminogen activator levels in myocardial infarction: a case-control study.
    Abboud N, Ghazouani L, Saidi S, Ben-Hadj-Khalifa S, Addad F, Almawi WY, Mahjoub T.
    Genet Test Mol Biomarkers; 2010 Feb; 14(1):23-7. PubMed ID: 19929406
    [Abstract] [Full Text] [Related]

  • 3. Plasminogen activator inhibitor-1 (PAI-1) 4 G/5 G polymorphism and endometrial cancer. Influence of PAI-1 polymorphism on tissue PAI-1 antigen and mRNA expression and tumor severity.
    Gilabert-Estellés J, Ramón LA, Braza-Boïls A, Gilabert J, Chirivella M, España F, Estellés A.
    Thromb Res; 2012 Aug; 130(2):242-7. PubMed ID: 22055623
    [Abstract] [Full Text] [Related]

  • 4. Association between plasminogen activator inhibitor‑1 (PAI-1) 4G/5G polymorphism and circulating PAI-1 level in systemic lupus erythematosus and rheumatoid arthritis : A meta-analysis.
    Bae SC, Lee YH.
    Z Rheumatol; 2020 Apr; 79(3):312-318. PubMed ID: 31428858
    [Abstract] [Full Text] [Related]

  • 5. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
    Sartori MT, Wiman B, Vettore S, Dazzi F, Girolami A, Patrassi GM.
    Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
    [Abstract] [Full Text] [Related]

  • 6. Association of PAI-1 4G/5G and -844G/A gene polymorphism and changes in PAI-1/tPA levels in stroke: a case-control study.
    Saidi S, Slamia LB, Mahjoub T, Ammou SB, Almawi WY.
    J Stroke Cerebrovasc Dis; 2007 Dec; 16(4):153-9. PubMed ID: 17689411
    [Abstract] [Full Text] [Related]

  • 7. The -675 4G/5G PAI-1 polymorphism confers genetic susceptibility to systemic lupus erythematosus, its clinical manifestations, and comorbidities in Mexican-Mestizo population.
    Anaya-Macias BU, De la Cruz-Mosso U, Palafox-Sánchez CA, Parra-Rojas I, Martínez-Bonilla G, González-López L, Gámez-Nava JI, Pérez-Guerrero EE, Barrientos-Avalos SL, Muñoz-Valle JF.
    Autoimmunity; 2020 Mar; 53(2):71-77. PubMed ID: 31829037
    [Abstract] [Full Text] [Related]

  • 8. Plasminogen activator inhibitor 1 expression in platelets is not influenced by the 4G/5G promoter polymorphism.
    Brogren H, Wallmark K, Jern S, Karlsson L.
    Thromb Res; 2008 Mar; 121(6):793-7. PubMed ID: 17884148
    [Abstract] [Full Text] [Related]

  • 9. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and endometriosis. Influence of PAI-1 polymorphism on PAI-1 antigen and mRNA expression.
    Ramón LA, Gilabert-Estellés J, Cosín R, Gilabert J, España F, Castelló R, Chirivella M, Romeu A, Estellés A.
    Thromb Res; 2008 Mar; 122(6):854-60. PubMed ID: 18423526
    [Abstract] [Full Text] [Related]

  • 10. The -844 G/A PAI-1 polymorphism is associated with mRNA expression in rheumatoid arthritis.
    Torres-Carrillo NM, Torres-Carrillo N, Vázquez-Del Mercado M, Delgado-Rizo V, Oregón-Romero E, Parra-Rojas I, Muñoz-Valle JF.
    Rheumatol Int; 2008 Feb; 28(4):355-60. PubMed ID: 17899094
    [Abstract] [Full Text] [Related]

  • 11. Association between the -844 G>A, HindIII C>G, and 4G/5G PAI-1 Polymorphisms and Susceptibility to Multiple Sclerosis in Western Mexican Population.
    Valdés-Alvarado E, Huerta M, Trujillo X, Valle Y, Padilla Gutiérrez JR, Mireles-Ramírez MA, Macías-Islas MA, Luz Margarita BR, Muñoz-Valle JF.
    Dis Markers; 2019 Feb; 2019():9626289. PubMed ID: 31687051
    [Abstract] [Full Text] [Related]

  • 12. A study of the possible association of plasminogen activator inhibitor type 1 4G/5G insertion/deletion polymorphism with susceptibility to schizophrenia and in its subtypes.
    Yenilmez C, Ozdemir Koroglu Z, Kurt H, Yanas M, Colak E, Degirmenci I, Gunes HV.
    J Clin Pharm Ther; 2017 Feb; 42(1):103-107. PubMed ID: 27796029
    [Abstract] [Full Text] [Related]

  • 13. Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity.
    Castelló R, España F, Vázquez C, Fuster C, Almenar SM, Aznar J, Estellés A.
    Thromb Res; 2006 Feb; 117(5):487-92. PubMed ID: 15907980
    [Abstract] [Full Text] [Related]

  • 14. Plasminogen activator inhibitor type 1 serum levels and 4G/5G gene polymorphism in morbidly obese Hispanic patients with non-alcoholic fatty liver disease.
    Espino A, Villagrán A, Vollrath V, Hanckes P, Salas R, Farah A, Solís N, Pizarro M, Escalona A, Boza C, Pérez G, Carrasco G, Padilla O, Miquel JF, Nervi F, Chavez-Tapia NC, Arab JP, Alvarez-Lobos M, Arrese M, Riquelme A.
    Ann Hepatol; 2011 Feb; 10(4):493-501. PubMed ID: 21911891
    [Abstract] [Full Text] [Related]

  • 15. Association of plasminogen activator inhibitor-1 gene polymorphism and type 2 diabetic nephropathy.
    Xu F, Liu H, Sun Y.
    Ren Fail; 2016 Feb; 38(1):157-62. PubMed ID: 26616527
    [Abstract] [Full Text] [Related]

  • 16. The plasminogen activator inhibitor-1 (PAI-1) gene -844 A/G and -675 4G/5G promoter polymorphism significantly influences plasma PAI-1 levels in women with polycystic ovary syndrome.
    Lin S, Huiya Z, Bo L, Wei W, Yongmei G.
    Endocrine; 2009 Dec; 36(3):503-9. PubMed ID: 19856137
    [Abstract] [Full Text] [Related]

  • 17. Relationship between gene polymorphism of the PAI-1 promoter and myocardial infarction.
    Fu L, Jin H, Song K, Zhang C, Shen J, Huang Y.
    Chin Med J (Engl); 2001 Mar; 114(3):266-9. PubMed ID: 11780311
    [Abstract] [Full Text] [Related]

  • 18. Plasminogen activator inhibitor-1 C/G polymorphism in relation to plasma levels in rheumatoid arthritis.
    Torres-Carrillo N, Torres-Carrillo NM, Martínez-Bonilla GE, Vázquez-Del Mercado M, Palafox-Sánchez CA, Oregón-Romero E, Bernard-Medina AG, Rangel-Villalobos H, Muñoz-Valle JF.
    Clin Exp Med; 2009 Sep; 9(3):223-8. PubMed ID: 19238514
    [Abstract] [Full Text] [Related]

  • 19. Genotype frequency of plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism in healthy Japanese males and its relation to PAI-1 levels.
    Matsubara Y, Murata M, Isshiki I, Watanabe R, Zama T, Watanabe G, Watanabe K, Ikeda Y.
    Int J Hematol; 1999 Jan; 69(1):43-7. PubMed ID: 10641442
    [Abstract] [Full Text] [Related]

  • 20. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.
    Stegnar M, Uhrin P, Peternel P, Mavri A, Salobir-Pajnic B, Stare J, Binder BR.
    Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.